カテゴリー： GlobalInfoResearch, 世界, 部品/材料

分化型甲状腺癌治療薬の世界市場2022：放射性ヨウ素内用療法、甲状腺刺激ホルモン（THS）抑制療法、化学療法、マルチキナーゼ療法、その他

◆英語タイトル：Global Differentiated Thyroid Cancer Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22DC0488）◆商品コード：GIR22DC0488
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2023年1月
◆ページ数：90
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界の分化型甲状腺癌治療薬市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の分化型甲状腺癌治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

分化型甲状腺癌治療薬市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・放射性ヨウ素内用療法、甲状腺刺激ホルモン（THS）抑制療法、化学療法、マルチキナーゼ療法、その他

アプリケーション別セグメントは次のように区分されます。
・病院、腫瘍学センター、病院薬局、小売薬局

世界の分化型甲状腺癌治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Mylan pharmaceuticals、Takeda、Alara Pharmaceutical、Abbott laboratories、Bristol Myers、Teva、Jerome Stevens

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、分化型甲状腺癌治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な分化型甲状腺癌治療薬メーカーの企業概要、2019年～2022年までの分化型甲状腺癌治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な分化型甲状腺癌治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別分化型甲状腺癌治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの分化型甲状腺癌治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での分化型甲状腺癌治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および分化型甲状腺癌治療薬の産業チェーンを掲載しています。
・第13、14、15章では、分化型甲状腺癌治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 分化型甲状腺癌治療薬の概要
– 種類別分析（2017年vs2021年vs2028年）：放射性ヨウ素内用療法、甲状腺刺激ホルモン（THS）抑制療法、化学療法、マルチキナーゼ療法、その他
– 用途別分析（2017年vs2021年vs2028年）：病院、腫瘍学センター、病院薬局、小売薬局
– 世界の分化型甲状腺癌治療薬市場規模・予測
– 世界の分化型甲状腺癌治療薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Mylan pharmaceuticals、Takeda、Alara Pharmaceutical、Abbott laboratories、Bristol Myers、Teva、Jerome Stevens
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：放射性ヨウ素内用療法、甲状腺刺激ホルモン（THS）抑制療法、化学療法、マルチキナーゼ療法、その他
・用途別分析2017年-2028年：病院、腫瘍学センター、病院薬局、小売薬局
・分化型甲状腺癌治療薬の北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・分化型甲状腺癌治療薬のヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・分化型甲状腺癌治療薬のアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・分化型甲状腺癌治療薬の南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・分化型甲状腺癌治療薬の中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Differentiated Thyroid Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Differentiated Thyroid Cancer Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Radioiodine Ablation
1.2.3 Thyroid Stimulating Hormone (THS) Suppression
1.2.4 Chemotherapy
1.2.5 Targeted Multikinase Therapy
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Differentiated Thyroid Cancer Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Oncology Canters
1.3.4 Hospital Pharmacies
1.3.5 Retail Pharmacies
1.4 Global Differentiated Thyroid Cancer Drugs Market Size & Forecast
1.4.1 Global Differentiated Thyroid Cancer Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Differentiated Thyroid Cancer Drugs Sales in Volume (2017-2028)
1.4.3 Global Differentiated Thyroid Cancer Drugs Price (2017-2028)
1.5 Global Differentiated Thyroid Cancer Drugs Production Capacity Analysis
1.5.1 Global Differentiated Thyroid Cancer Drugs Total Production Capacity (2017-2028)
1.5.2 Global Differentiated Thyroid Cancer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Differentiated Thyroid Cancer Drugs Market Drivers
1.6.2 Differentiated Thyroid Cancer Drugs Market Restraints
1.6.3 Differentiated Thyroid Cancer Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Mylan pharmaceuticals
2.1.1 Mylan pharmaceuticals Details
2.1.2 Mylan pharmaceuticals Major Business
2.1.3 Mylan pharmaceuticals Differentiated Thyroid Cancer Drugs Product and Services
2.1.4 Mylan pharmaceuticals Differentiated Thyroid Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Differentiated Thyroid Cancer Drugs Product and Services
2.2.4 Takeda Differentiated Thyroid Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Alara Pharmaceutical
2.3.1 Alara Pharmaceutical Details
2.3.2 Alara Pharmaceutical Major Business
2.3.3 Alara Pharmaceutical Differentiated Thyroid Cancer Drugs Product and Services
2.3.4 Alara Pharmaceutical Differentiated Thyroid Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Abbott laboratories
2.4.1 Abbott laboratories Details
2.4.2 Abbott laboratories Major Business
2.4.3 Abbott laboratories Differentiated Thyroid Cancer Drugs Product and Services
2.4.4 Abbott laboratories Differentiated Thyroid Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bristol Myers
2.5.1 Bristol Myers Details
2.5.2 Bristol Myers Major Business
2.5.3 Bristol Myers Differentiated Thyroid Cancer Drugs Product and Services
2.5.4 Bristol Myers Differentiated Thyroid Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business
2.6.3 Teva Differentiated Thyroid Cancer Drugs Product and Services
2.6.4 Teva Differentiated Thyroid Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Jerome Stevens
2.7.1 Jerome Stevens Details
2.7.2 Jerome Stevens Major Business
2.7.3 Jerome Stevens Differentiated Thyroid Cancer Drugs Product and Services
2.7.4 Jerome Stevens Differentiated Thyroid Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Differentiated Thyroid Cancer Drugs Breakdown Data by Manufacturer
3.1 Global Differentiated Thyroid Cancer Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Differentiated Thyroid Cancer Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Differentiated Thyroid Cancer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Differentiated Thyroid Cancer Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Differentiated Thyroid Cancer Drugs Manufacturer Market Share in 2021
3.5 Global Differentiated Thyroid Cancer Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Differentiated Thyroid Cancer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Differentiated Thyroid Cancer Drugs Market Size by Region
4.1.1 Global Differentiated Thyroid Cancer Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Differentiated Thyroid Cancer Drugs Revenue by Region (2017-2028)
4.2 North America Differentiated Thyroid Cancer Drugs Revenue (2017-2028)
4.3 Europe Differentiated Thyroid Cancer Drugs Revenue (2017-2028)
4.4 Asia-Pacific Differentiated Thyroid Cancer Drugs Revenue (2017-2028)
4.5 South America Differentiated Thyroid Cancer Drugs Revenue (2017-2028)
4.6 Middle East and Africa Differentiated Thyroid Cancer Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Differentiated Thyroid Cancer Drugs Sales in Volume by Type (2017-2028)
5.2 Global Differentiated Thyroid Cancer Drugs Revenue by Type (2017-2028)
5.3 Global Differentiated Thyroid Cancer Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Differentiated Thyroid Cancer Drugs Sales in Volume by Application (2017-2028)
6.2 Global Differentiated Thyroid Cancer Drugs Revenue by Application (2017-2028)
6.3 Global Differentiated Thyroid Cancer Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Differentiated Thyroid Cancer Drugs Sales by Type (2017-2028)
7.2 North America Differentiated Thyroid Cancer Drugs Sales by Application (2017-2028)
7.3 North America Differentiated Thyroid Cancer Drugs Market Size by Country
7.3.1 North America Differentiated Thyroid Cancer Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Differentiated Thyroid Cancer Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Differentiated Thyroid Cancer Drugs Sales by Type (2017-2028)
8.2 Europe Differentiated Thyroid Cancer Drugs Sales by Application (2017-2028)
8.3 Europe Differentiated Thyroid Cancer Drugs Market Size by Country
8.3.1 Europe Differentiated Thyroid Cancer Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Differentiated Thyroid Cancer Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Differentiated Thyroid Cancer Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Differentiated Thyroid Cancer Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Differentiated Thyroid Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Differentiated Thyroid Cancer Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Differentiated Thyroid Cancer Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Differentiated Thyroid Cancer Drugs Sales by Type (2017-2028)
10.2 South America Differentiated Thyroid Cancer Drugs Sales by Application (2017-2028)
10.3 South America Differentiated Thyroid Cancer Drugs Market Size by Country
10.3.1 South America Differentiated Thyroid Cancer Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Differentiated Thyroid Cancer Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Differentiated Thyroid Cancer Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Differentiated Thyroid Cancer Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Differentiated Thyroid Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Differentiated Thyroid Cancer Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Differentiated Thyroid Cancer Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Differentiated Thyroid Cancer Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Differentiated Thyroid Cancer Drugs
12.3 Differentiated Thyroid Cancer Drugs Production Process
12.4 Differentiated Thyroid Cancer Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Differentiated Thyroid Cancer Drugs Typical Distributors
13.3 Differentiated Thyroid Cancer Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Differentiated Thyroid Cancer Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Differentiated Thyroid Cancer Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Mylan pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Mylan pharmaceuticals Major Business
Table 5. Mylan pharmaceuticals Differentiated Thyroid Cancer Drugs Product and Services
Table 6. Mylan pharmaceuticals Differentiated Thyroid Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Takeda Basic Information, Manufacturing Base and Competitors
Table 8. Takeda Major Business
Table 9. Takeda Differentiated Thyroid Cancer Drugs Product and Services
Table 10. Takeda Differentiated Thyroid Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Alara Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Alara Pharmaceutical Major Business
Table 13. Alara Pharmaceutical Differentiated Thyroid Cancer Drugs Product and Services
Table 14. Alara Pharmaceutical Differentiated Thyroid Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Abbott laboratories Basic Information, Manufacturing Base and Competitors
Table 16. Abbott laboratories Major Business
Table 17. Abbott laboratories Differentiated Thyroid Cancer Drugs Product and Services
Table 18. Abbott laboratories Differentiated Thyroid Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bristol Myers Basic Information, Manufacturing Base and Competitors
Table 20. Bristol Myers Major Business
Table 21. Bristol Myers Differentiated Thyroid Cancer Drugs Product and Services
Table 22. Bristol Myers Differentiated Thyroid Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Teva Basic Information, Manufacturing Base and Competitors
Table 24. Teva Major Business
Table 25. Teva Differentiated Thyroid Cancer Drugs Product and Services
Table 26. Teva Differentiated Thyroid Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Jerome Stevens Basic Information, Manufacturing Base and Competitors
Table 28. Jerome Stevens Major Business
Table 29. Jerome Stevens Differentiated Thyroid Cancer Drugs Product and Services
Table 30. Jerome Stevens Differentiated Thyroid Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Differentiated Thyroid Cancer Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Differentiated Thyroid Cancer Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Differentiated Thyroid Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Differentiated Thyroid Cancer Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Differentiated Thyroid Cancer Drugs Production Site of Key Manufacturer
Table 36. Differentiated Thyroid Cancer Drugs New Entrant and Capacity Expansion Plans
Table 37. Differentiated Thyroid Cancer Drugs Mergers & Acquisitions in the Past Five Years
Table 38. Global Differentiated Thyroid Cancer Drugs Sales by Region (2017-2022) & (K Units)
Table 39. Global Differentiated Thyroid Cancer Drugs Sales by Region (2023-2028) & (K Units)
Table 40. Global Differentiated Thyroid Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Differentiated Thyroid Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Differentiated Thyroid Cancer Drugs Sales by Type (2017-2022) & (K Units)
Table 43. Global Differentiated Thyroid Cancer Drugs Sales by Type (2023-2028) & (K Units)
Table 44. Global Differentiated Thyroid Cancer Drugs Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Differentiated Thyroid Cancer Drugs Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Differentiated Thyroid Cancer Drugs Price by Type (2017-2022) & (USD/Unit)
Table 47. Global Differentiated Thyroid Cancer Drugs Price by Type (2023-2028) & (USD/Unit)
Table 48. Global Differentiated Thyroid Cancer Drugs Sales by Application (2017-2022) & (K Units)
Table 49. Global Differentiated Thyroid Cancer Drugs Sales by Application (2023-2028) & (K Units)
Table 50. Global Differentiated Thyroid Cancer Drugs Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Differentiated Thyroid Cancer Drugs Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Differentiated Thyroid Cancer Drugs Price by Application (2017-2022) & (USD/Unit)
Table 53. Global Differentiated Thyroid Cancer Drugs Price by Application (2023-2028) & (USD/Unit)
Table 54. North America Differentiated Thyroid Cancer Drugs Sales by Country (2017-2022) & (K Units)
Table 55. North America Differentiated Thyroid Cancer Drugs Sales by Country (2023-2028) & (K Units)
Table 56. North America Differentiated Thyroid Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Differentiated Thyroid Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Differentiated Thyroid Cancer Drugs Sales by Type (2017-2022) & (K Units)
Table 59. North America Differentiated Thyroid Cancer Drugs Sales by Type (2023-2028) & (K Units)
Table 60. North America Differentiated Thyroid Cancer Drugs Sales by Application (2017-2022) & (K Units)
Table 61. North America Differentiated Thyroid Cancer Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Europe Differentiated Thyroid Cancer Drugs Sales by Country (2017-2022) & (K Units)
Table 63. Europe Differentiated Thyroid Cancer Drugs Sales by Country (2023-2028) & (K Units)
Table 64. Europe Differentiated Thyroid Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Differentiated Thyroid Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Differentiated Thyroid Cancer Drugs Sales by Type (2017-2022) & (K Units)
Table 67. Europe Differentiated Thyroid Cancer Drugs Sales by Type (2023-2028) & (K Units)
Table 68. Europe Differentiated Thyroid Cancer Drugs Sales by Application (2017-2022) & (K Units)
Table 69. Europe Differentiated Thyroid Cancer Drugs Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Differentiated Thyroid Cancer Drugs Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Differentiated Thyroid Cancer Drugs Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Differentiated Thyroid Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Differentiated Thyroid Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Differentiated Thyroid Cancer Drugs Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Differentiated Thyroid Cancer Drugs Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Differentiated Thyroid Cancer Drugs Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Differentiated Thyroid Cancer Drugs Sales by Application (2023-2028) & (K Units)
Table 78. South America Differentiated Thyroid Cancer Drugs Sales by Country (2017-2022) & (K Units)
Table 79. South America Differentiated Thyroid Cancer Drugs Sales by Country (2023-2028) & (K Units)
Table 80. South America Differentiated Thyroid Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Differentiated Thyroid Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Differentiated Thyroid Cancer Drugs Sales by Type (2017-2022) & (K Units)
Table 83. South America Differentiated Thyroid Cancer Drugs Sales by Type (2023-2028) & (K Units)
Table 84. South America Differentiated Thyroid Cancer Drugs Sales by Application (2017-2022) & (K Units)
Table 85. South America Differentiated Thyroid Cancer Drugs Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Differentiated Thyroid Cancer Drugs Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Differentiated Thyroid Cancer Drugs Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Differentiated Thyroid Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Differentiated Thyroid Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Differentiated Thyroid Cancer Drugs Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Differentiated Thyroid Cancer Drugs Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Differentiated Thyroid Cancer Drugs Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Differentiated Thyroid Cancer Drugs Sales by Application (2023-2028) & (K Units)
Table 94. Differentiated Thyroid Cancer Drugs Raw Material
Table 95. Key Manufacturers of Differentiated Thyroid Cancer Drugs Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Differentiated Thyroid Cancer Drugs Typical Distributors
Table 99. Differentiated Thyroid Cancer Drugs Typical Customers
List of Figures
Figure 1. Differentiated Thyroid Cancer Drugs Picture
Figure 2. Global Differentiated Thyroid Cancer Drugs Revenue Market Share by Type in 2021
Figure 3. Radioiodine Ablation
Figure 4. Thyroid Stimulating Hormone (THS) Suppression
Figure 5. Chemotherapy
Figure 6. Targeted Multikinase Therapy
Figure 7. Others
Figure 8. Global Differentiated Thyroid Cancer Drugs Revenue Market Share by Application in 2021
Figure 9. Hospitals
Figure 10. Oncology Canters
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Global Differentiated Thyroid Cancer Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Differentiated Thyroid Cancer Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Differentiated Thyroid Cancer Drugs Sales (2017-2028) & (K Units)
Figure 16. Global Differentiated Thyroid Cancer Drugs Price (2017-2028) & (USD/Unit)
Figure 17. Global Differentiated Thyroid Cancer Drugs Production Capacity (2017-2028) & (K Units)
Figure 18. Global Differentiated Thyroid Cancer Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Differentiated Thyroid Cancer Drugs Market Drivers
Figure 20. Differentiated Thyroid Cancer Drugs Market Restraints
Figure 21. Differentiated Thyroid Cancer Drugs Market Trends
Figure 22. Global Differentiated Thyroid Cancer Drugs Sales Market Share by Manufacturer in 2021
Figure 23. Global Differentiated Thyroid Cancer Drugs Revenue Market Share by Manufacturer in 2021
Figure 24. Differentiated Thyroid Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Differentiated Thyroid Cancer Drugs Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Differentiated Thyroid Cancer Drugs Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Differentiated Thyroid Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 28. Global Differentiated Thyroid Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 29. North America Differentiated Thyroid Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Europe Differentiated Thyroid Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Differentiated Thyroid Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 32. South America Differentiated Thyroid Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Differentiated Thyroid Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Global Differentiated Thyroid Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 35. Global Differentiated Thyroid Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 36. Global Differentiated Thyroid Cancer Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 37. Global Differentiated Thyroid Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 38. Global Differentiated Thyroid Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 39. Global Differentiated Thyroid Cancer Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Differentiated Thyroid Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 41. North America Differentiated Thyroid Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 42. North America Differentiated Thyroid Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 43. North America Differentiated Thyroid Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 44. United States Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Differentiated Thyroid Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 48. Europe Differentiated Thyroid Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 49. Europe Differentiated Thyroid Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 50. Europe Differentiated Thyroid Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 51. Germany Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Differentiated Thyroid Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Differentiated Thyroid Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Differentiated Thyroid Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Differentiated Thyroid Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 60. China Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Differentiated Thyroid Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 67. South America Differentiated Thyroid Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 68. South America Differentiated Thyroid Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 69. South America Differentiated Thyroid Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Differentiated Thyroid Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Differentiated Thyroid Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Differentiated Thyroid Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Differentiated Thyroid Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Differentiated Thyroid Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Differentiated Thyroid Cancer Drugs in 2021
Figure 81. Manufacturing Process Analysis of Differentiated Thyroid Cancer Drugs
Figure 82. Differentiated Thyroid Cancer Drugs Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 分化型甲状腺癌治療薬の世界市場2022：放射性ヨウ素内用療法、甲状腺刺激ホルモン（THS）抑制療法、化学療法、マルチキナーゼ療法、その他(Global Differentiated Thyroid Cancer Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の肝がん治療薬市場2023-2030：薬剤クラス別（標的療法、免疫療法、化学療法）、地域別
  • 膵臓がん転移治療のグローバル市場2023年：化学療法、標的療法、その他
  • 血液検査のグローバル市場2023-2030：ブドウ糖、脂質、新型コロナウイルス感染症、A1C、CRP、ビタミンD、ALT、AST、甲状腺刺激ホルモン、PSA、コルチゾール

    • ◆H&Iグローバルリサーチのお客様（例）◆